Tag: BCRX

By Posted on Posted in Uncategorised

Fundamental Valuation Report Acorda Therapeutics(ACOR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.74 (USD) 28/02/2019 Weighted Valuation$21.10 (USD) Overall RatingUndervalued by 43.2% Valuation Models Analyst Consensus: $23.67 (USD) (in …

Acorda Therapeutics (ACOR:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Apellis Pharmaceuticals(APLS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.24 (USD) 27/02/2019 Weighted Valuation$37.26 (USD) Overall RatingUndervalued by 161.7% Valuation Models Analyst Consensus: $53.00 (USD) (in …

Apellis Pharmaceuticals (APLS:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Alder BioPharmaceuticals(ALDR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$13.51 (USD) 26/02/2019 Weighted Valuation$15.36 (USD) Overall RatingUndervalued by 13.7% Valuation Models Analyst Consensus: $17.80 (USD) (in …

Alder BioPharmaceuticals (ALDR:NAS) Fundamental Valuation Report Read more »

Read More